Javascript must be enabled to continue!
IgG sialylation occurs via the FcRn-mediated recycling pathway in endothelial cells
View through CrossRef
Abstract
IgG is a key mediator of immune responses throughout the human body, and the structure of the conserved glycan on the Fc region has been identified as a key inflammatory switch regulating its downstream effects. In particular, the absence of terminal sialic acid has been shown to increase the affinity of IgG for activating Fc receptors, cascading the inflammatory response in a variety of diseases and conditions. Previously, we have shown that IgG sialylation is mediated by B cell-extrinsic processes. Here, we show that the FcRn-mediated recycling pathway within endothelial cells is a critical modulator of IgG sialylation. Building a deeper understanding of how IgG sialylation is regulated will drive the development of novel therapeutics which dynamically tune IgG functionality
in vivo
.
One-Sentence Summary
Endothelial cells remodel IgG glycans within the FcRn-mediated recycling pathway.
Title: IgG sialylation occurs via the FcRn-mediated recycling pathway in endothelial cells
Description:
Abstract
IgG is a key mediator of immune responses throughout the human body, and the structure of the conserved glycan on the Fc region has been identified as a key inflammatory switch regulating its downstream effects.
In particular, the absence of terminal sialic acid has been shown to increase the affinity of IgG for activating Fc receptors, cascading the inflammatory response in a variety of diseases and conditions.
Previously, we have shown that IgG sialylation is mediated by B cell-extrinsic processes.
Here, we show that the FcRn-mediated recycling pathway within endothelial cells is a critical modulator of IgG sialylation.
Building a deeper understanding of how IgG sialylation is regulated will drive the development of novel therapeutics which dynamically tune IgG functionality
in vivo
.
One-Sentence Summary
Endothelial cells remodel IgG glycans within the FcRn-mediated recycling pathway.
Related Results
Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential
Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential
Abstract
Background
Optimizing the IgG Fc domain for neonatal Fc receptor (FcRn) binding is crucial for enhancing antibod...
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
Quantitative real-time PCR and Western blot methods were developed to assess neonatal Fc-receptor (FcRn) mRNA and protein expression in human FcRn transgenic mice, Swiss Webster mi...
Divergent Golgi trafficking limits B cell-mediated IgG sialylation
Divergent Golgi trafficking limits B cell-mediated IgG sialylation
Abstract
The degree of α2,6-linked sialylation on IgG glycans is associated with a variety of inflammatory conditions and is thought to drive IgG anti-inflammator...
Divergent Golgi Trafficking Limits B cell-Mediated IgG Sialylation
Divergent Golgi Trafficking Limits B cell-Mediated IgG Sialylation
Abstract
The degree of α2,6-linked sialylation on IgG glycans is associated with a variety of inflammatory conditions and is thought to drive IgG...
Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography
Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography
Abstract
Molecular interactions between therapeutic antibodies and neonatal Fc receptor (FcRn) are major contributors to the long serum half-life of antibodies. T...
FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
Monoclonal antibodies (mAbs) are promising therapies to treat airway chronic inflammatory disease (asthma or nasal polyps). To date, no study has specifically assessed, in vitro, t...
ST6Gal1 in plasma is dispensable for IgG sialylation
ST6Gal1 in plasma is dispensable for IgG sialylation
Abstract
The glycosylation of immunoglobulin G (IgG) has attracted increased attention due to the impact of N-glycan modifications at N297 on IgG function, acting...
Endothelial cells sialylate IgG within the FcRn-mediated recycling pathway
Endothelial cells sialylate IgG within the FcRn-mediated recycling pathway
IgG is a key to adaptive immunity and a critical platform for drug design. Sialic acid on the conserved glycan within the Fc domain is believed to promote anti-inflammatory IgG fun...

